Inventor
KULYK SVITLANA
US12 patents
⚠️ This page may combine multiple inventors who share the name “KULYK SVITLANA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MIRATI THERAPEUTICS INC
7 patentsUS12421253B2Sep 23, 2025
Tetrahydropyridopyrimidine pan-KRas inhibitors
MIRATI THERAPEUTICS INC1 citations63
US12304915B2May 20, 2025
SOS1 inhibitors
MIRATI THERAPEUTICS INC0 citations61
US11999753B2Jun 4, 2024
Tetrahydropyridopyrimidine pan-KRas inhibitors
MIRATI THERAPEUTICS INC1 citations61
US11702418B2Jul 18, 2023
SOS1 inhibitors
MIRATI THERAPEUTICS INC0 citations61
US11492351B2Nov 8, 2022
MTA-cooperative PRMT5 inhibitors
MIRATI THERAPEUTICS INC0 citations61
US11479551B2Oct 25, 2022
MTA-cooperative PRMT5 inhibitors
MIRATI THERAPEUTICS INC1 citations61
US12398154B2Aug 26, 2025
Azaquinazoline pan-KRas inhibitors
MIRATI THERAPEUTICS INC0 citations51
THERAVANCE BIOPHARMA R&D IP LLC
4 patentsUS10952996B2Mar 23, 2021
ALK5 inhibitors
THERAVANCE BIOPHARMA R&D IP LLC2 citations71
US11730720B2Aug 22, 2023
ALK5 inhibitors
THERAVANCE BIOPHARMA R&D IP LLC0 citations60
US11590116B2Feb 28, 2023
Substituted pyridines and methods of use
THERAVANCE BIOPHARMA R&D IP LLC1 citations60
US11673879B2Jun 13, 2023
Substituted pyrimidines and methods of use
THERAVANCE BIOPHARMA R&D IP LLC0 citations50